59/100BPfizer company profile
- CEO
- Albert Bourla
- Employees
- 75,000
- Headquarters
- 66 Hudson Boulevard East, New York City, NY 10001-2192, US
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- IPO date
- 1 Jun 1972
- Stock exchange
- NYSE
- ISIN
- US7170811035
Website:pfizer.com
About the company
Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.
Employees
Pfizer had about 75,000 employees at the end of fiscal year 2025 (31 December 2025), by its annual report. That is 7.4% fewer than a year before.
Employees at each fiscal year end, as the company reports them in its annual report (10-K); revenue and net income per employee are the fiscal year's over that count.
Who owns Pfizer
Institutions such as funds, banks and insurers held 67.9% of Pfizer's shares on 30 June 2026, 2,965 of them reporting holdings to the SEC; the rest is held by individual investors and other shareholders.
Common questions about Pfizer
Source: Financial Modeling Prep